Search Results 5211-5220 of 17106 for mesenteric fat and ibd
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.
-
About this study. To assess the response of persistent Barrett's Esophagus and/or dysplasia to focal cyro ablation .
-
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...
-
Panobinostat and everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
-
About this study. The objectives of this study are to establish and perpetuate human biliary cell-derived organoids, to assess genetic and signaling pathway ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
About this study. The purpose of this study is to assess intravascular volume heterogeneity in relation to neuroendocrine profiles in patients admitted to ...
-
The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult subjects with NASH.
-
About this study. Primary Biliary Cirrhosis (PBC) is a serious, life--threatening, bile acid related liver disease of unknown cause.